Adenovirus News and Research

RSS
Adenoviruses most commonly cause respiratory illness; however, depending on the infecting serotype, they may also cause various other illnesses, such as gastroenteritis, conjunctivitis, cystitis, and rash illness. Symptoms of respiratory illness caused by adenovirus infection range from the common cold syndrome to pneumonia, croup, and bronchitis. Patients with compromised immune systems are especially susceptible to severe complications of adenovirus infection. Acute respiratory disease (ARD), first recognized among military recruits during World War II, can be caused by adenovirus infections during conditions of crowding and stress.
UK public health authorities review early data on the effectiveness of Pfizer and AstraZeneca COVID-19 vaccines

UK public health authorities review early data on the effectiveness of Pfizer and AstraZeneca COVID-19 vaccines

Delayed second dose strategy with mRNA vaccines may reduce COVID-19 mortality, say researchers

Delayed second dose strategy with mRNA vaccines may reduce COVID-19 mortality, say researchers

SARS-CoV-2 viremia predicts severe COVID-19 disease outcomes

SARS-CoV-2 viremia predicts severe COVID-19 disease outcomes

FDA issues EUA for third COVID-19 vaccine

FDA issues EUA for third COVID-19 vaccine

Why Astrazeneca and J&J’s vaccines, in use the world over, are still on hold in America

Why Astrazeneca and J&J’s vaccines, in use the world over, are still on hold in America

Study explores individual differences of SARS-CoV-2 infection in ACE2-expressing stem cells

Study explores individual differences of SARS-CoV-2 infection in ACE2-expressing stem cells

An overview of spike protein antigen COVID-19 vaccine candidates

An overview of spike protein antigen COVID-19 vaccine candidates

Could measles virus vectors be used for a new COVID-19 vaccine?

Could measles virus vectors be used for a new COVID-19 vaccine?

New mouse model of SARS-CoV-2 infection reflects features of human infection

New mouse model of SARS-CoV-2 infection reflects features of human infection

Cell-selective nanotherapy can help treat atherosclerotic plaques

Cell-selective nanotherapy can help treat atherosclerotic plaques

One-dose SARS-CoV-2 vaccine policy may lead to antigenic evolution, study finds

One-dose SARS-CoV-2 vaccine policy may lead to antigenic evolution, study finds

ZyCoV-D SARS-CoV-2 DNA vaccine shows robust immunogenicity and protective efficacy in Rhesus macaquesys

ZyCoV-D SARS-CoV-2 DNA vaccine shows robust immunogenicity and protective efficacy in Rhesus macaquesys

Russia's Sputnik V COVID-19 shown to have 91.6 percent efficacy

Russia's Sputnik V COVID-19 shown to have 91.6 percent efficacy

Experimental intranasal influenza vaccine produces durable immune response

Experimental intranasal influenza vaccine produces durable immune response

J&J SARS-CoV-2 vaccine shows immunity in non-human primates 6 months after vaccination

J&J SARS-CoV-2 vaccine shows immunity in non-human primates 6 months after vaccination

Two-dose regimen of adenovirus-based vaccine offers 91.6% efficacy against COVID-19

Two-dose regimen of adenovirus-based vaccine offers 91.6% efficacy against COVID-19

Johnson & Johnson SARS-CoV-2 vaccine shows promise in clinical trials

Johnson & Johnson SARS-CoV-2 vaccine shows promise in clinical trials

ZyCoV-D DNA vaccine immunogenic against SARS-CoV-2 in animal models

ZyCoV-D DNA vaccine immunogenic against SARS-CoV-2 in animal models

Inhaled single dose vaccine creates antibodies and prevents infection in rhesus macaques

Inhaled single dose vaccine creates antibodies and prevents infection in rhesus macaques

What do we know about the SARS-CoV-2 vaccines so far?

What do we know about the SARS-CoV-2 vaccines so far?